Stock Analysis on Net

Boeing Co. (NYSE:BA)

$24.99

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Boeing Co., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Accounts payable
Accrued liabilities
Advances and progress billings
Short-term debt and current portion of long-term debt
Liabilities held for sale
Current liabilities
Deferred income taxes
Accrued retiree health care
Accrued pension plan liability, net
Other long-term liabilities
Long-term debt, excluding current portion
Long-term liabilities
Total liabilities
Mandatory convertible preferred stock, 6.00% Series A, par value $1.00
Common stock, par value $5.00
Additional paid-in capital
Treasury stock, at cost
Retained earnings
Accumulated other comprehensive loss
Shareholders’ deficit
Noncontrolling interests
Total deficit
Total liabilities and deficit

Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).


Accounts payable
The proportion of accounts payable relative to total liabilities and deficit decreased from 10.46% in March 2020 to a low of 6.46% by March 2022, followed by a gradual increase peaking at 8.91% in September 2024, before declining again to around 7.05%–7.24% by mid-2025. This indicates some initial reduction in short-term payables, with moderate fluctuations thereafter.
Accrued liabilities
Accrued liabilities consistently accounted for roughly 13% to 16% of total liabilities and deficit, with a slight upward trend starting around 15% in early 2020, peaking near 16.43% in September 2024, and then stabilizing around 15% to 15.15% towards mid-2025. This reflects persistent obligations accrued over the periods.
Advances and progress billings
This item steadily increased as a percentage of total liabilities and deficit from 36.96% in March 2020 to a peak of around 43.85% in March 2024. After that, it slightly declined yet remained high near 38% to 39% by mid-2025, suggesting growing unearned revenue or progress billings on contracts over time.
Short-term debt and current portion of long-term debt
The share fluctuated significantly, starting at 3.62% in March 2020, dropping below 1% at end 2020, rising again to 5.81% by December 2022, then alternating between roughly 0.7% and 5.6% in subsequent quarters through mid-2025. This pattern reflects variable reliance on short-term borrowings.
Current liabilities
Current liabilities as a proportion of total liabilities and deficit grew from 66.05% in March 2020 to around 70.66% in September 2024, followed by a decrease to approximately 66% by June 2025. This suggests increasing near-term obligations through 2024 with some reduction thereafter.
Deferred income taxes
Deferred income taxes remained a very small portion of total liabilities and deficit, generally below 1%, with minor fluctuations and no clear trend over the period.
Accrued retiree health care
There was a steady decline in this liability, decreasing from about 3.13% in early 2020 to approximately 1.36% by mid-2025, indicating reduced obligations related to retiree health benefits.
Accrued pension plan liability, net
A downward trend is evident, with this item declining from 11.16% in March 2020 to 3.74% by June 2025, reflecting a substantial reduction in pension liabilities over time.
Other long-term liabilities
These increased moderately over time, ranging from about 0.98% to 1.89%, showing a gradual build-up in other long-term obligations.
Long-term debt, excluding current portion
Long-term debt rose sharply from 23.59% in March 2020 to a peak of about 41% in December 2021, then declined steadily to 28.75% by June 2025, indicating deleveraging or refinancing efforts reducing long-term obligations.
Long-term liabilities
Long-term liabilities as a whole increased from approximately 40.49% in early 2020 to over 54% by the end of 2020, then showed a gradual decline to about 35.48% by mid-2025. This reflects an initial accumulation followed by a reduction in long-term financial commitments.
Total liabilities
The total liabilities proportion increased from 106.54% in March 2020 to a peak around 117.11% in September 2024, then decreased sharply to about 102.12% by mid-2025. The values above 100% suggest accounting factors related to deficit presentation, with fluctuations indicating changing liability structures.
Common stock and additional paid-in capital
Common stock showed a slight upward trend from 3.54% to around 3.76% before a minor decrease near 3.23% to 3.26% by mid-2025. Additional paid-in capital markedly increased from 4.61% in March 2020 to over 12% by mid-2025, indicating equity infusion or stock-based financing strengthening the capital base.
Treasury stock, at cost
The negative value associated with treasury stock decreased in magnitude from -38.33% in early 2020 to a significantly lower deficit around -20.37% by mid-2025, suggesting share repurchases were reduced or some treasury shares were reissued, thereby reducing the negative impact.
Retained earnings
Retained earnings declined considerably from 34.84% in March 2020 to below 10% by mid-2025, evidencing cumulative losses or significant dividend payouts affecting accumulated profits.
Accumulated other comprehensive loss
This loss item narrowed modestly from -11.42% in March 2020 to about -6.79% by June 2025, indicating some recovery or reduction in unrealized losses recorded in equity.
Shareholders’ deficit and total deficit
Both these measures exhibited substantial improvement during the time frame. The shareholders’ deficit worsened to nearly -17.1% in September 2024 but dramatically improved to around -2.12% by mid-2025, similar to the total deficit which recovered from nearly -12% range to the low negative single-digit figures. This reflects a significant strengthening of the equity position toward the end of the period.
Noncontrolling interests
Noncontrolling interests decreased gradually to negligible or slightly negative levels, indicating minimal minority ownership impact in the liabilities and deficit structure.